Actualmente no existe cura para la distrofia muscular de Becker. Investigaciones Investigaciones. Visite el enlace de ClinicalTrials. Organizaciones Organizaciones. Organizaciones de Apoyo para esta Enfermedad. Rivadavia PB Dto. Organizaciones de Apoyo General. Haga una pregunta nueva En mi familia hay muchos varones pero solamente tengo un hermano afectado con distrofia muscular de Becker.
Referencias Referencias. Duchenne and Becker muscular dystrophy. Genetics Home Reference. Becker's muscular dystrophy. Muscular Dystrophy, Becker. Mandac BR. Becker Muscular Dystrophy. Medscape Reference. Darras BT. Treatment of Duchenne and Becker Muscular Dystrophy. Muscular Dystrophy Association. Merkies, C. Crijns, C. Hereditary muscular dystrophies and the heart. Neuromuscul Disord, 20 , pp. Smith, J. Koreska, C. Progression of scoliosis in Duchenne muscular dystrophy. J Bone Joint Surg Am, 71 , pp.
McDonald, M. Kinali, A. Gallagher, E. Mercuri, F. Muntoni, H. Roper, et al. Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol, 44 , pp. Cotton, N. Voudouris, K. Intelligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients. Dev Med Child Neurol, 43 , pp.
Magri, A. Govoni, M. D'Angelo, R. Del Bo, S. Ghezzi, G. Sandra, et al. Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up. J Neurol, , pp. Bushby, A. Hill, J. Failure of early diagnosis in symptomatic Duchenne muscular dystrophy. Ciafaloni, D. Fox, S. Pandya, C. Westfield, S. Puzhankara, P. Romitti, et al. Delayed diagnosis in Duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance.
J Pediatr, , pp. Cyrulnik, R. Fee, D. De Vivo, E. Goldstein, V. Delayed developmental language milestones in children with Duchenne's muscular dystrophy. Zatz, D. Rapaport, M. Vainzof, M. Passos-Bueno, E. Bortolini, C. Pavanello R de, et al. J Neurol Sci, , pp. Abbs, S. Tuffery-Giraud, E. Bakker, A. Ferlini, T. Sejersen, C. Disorders of voluntary muscle, 8th, pp. Helderman-van den Enden, R. Houwing-Duistermaat, A.
Kneppers, H. Ginjaar, et al. Recurrence risk due to germ line mosaicism: Duchenne and Becker muscular dystrophy. Clin Genet, 75 , pp. Eagle, S. Baudouin, C. Chandler, D. Giddings, R. Bullock, K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since and the impact of home nocturnal ventilation. Neuromuscul Disord, 12 , pp.
Eagle, J. Bourke, R. Bullock, M. Gibson, J. Mehta, D. Giddings, et al. Managing Duchenne muscular dystrophy--the additive effect of spinal surgery and home nocturnal ventilation in improving survival. Neuromuscul Disord, 17 , pp. Manzur, T. Kuntzer, M. Pike, A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev, 1 , pp.
Ricotti, D. Ridout, E. Scott, R. Quinlivan, S. Robb, A. Manzur, et al. Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry, 84 , pp. Escolar, L. Hache, P. Clemens, A. Cnaan, C.
McDonald, V. Viswanathan, et al. Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy. Neurology, 2 , pp. Report on the muscular dystrophy campaign workshop: exercise in neuromuscular diseases Newcastle. Finder, D. Birnkrant, J. Carl, H. Farber, D. Gozal, S. Iannaccone, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Duboc, C. Meune, B. Pierre, K. Wahbi, B. Eymard, A.
Toutain, et al. Am Heart J, , pp. Segura, J. Lorenz, T. Weingarten, F. Scavonetto, K. Selcen, et al. Anesthesia and Duchenne or Becker muscular dystrophy: review of anesthetic exposures. Paediatr Anaesth, 23 , pp. Goemans, M. Tulinius, J. Burm, P. Ekhart, N. Heuvelmans, et al. Systemic administration of PRO in Duchenne's muscular dystrophy. Cirak, V. Arechavala-Gomeza, M. Guglieri, L. Feng, S. Torelli, K. Anyhony, et al. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.
Leung, K. Ann Neurol, 74 , pp. Bowles, S. McPhee, C. Li, S. Gray, J. Samilski, A. Camps, et al. Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector. Mol Ther, 20 , pp. Todos los derechos reservados. Are you a health professional able to prescribe or dispense drugs?
Problemas motores. Marcha de puntillas. Marcha con balanceo de caderas.
0コメント